| NAME |
GABAPENTIN (GRALISE) 300MG TAB,SA,UD |
| VA GENERIC NAME |
GABAPENTIN |
| DOSAGE FORM |
TAB,SA |
| FDA MED GUIDE |
Gabapentin_(Gralise)_(2023).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
300 |
| INACTIVATION DATE |
2016-03-15 00:00:00 |
| UNITS |
MG |
| NATIONAL FORMULARY NAME |
GABAPENTIN TAB,SA |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
GABAPENTIN (GRALISE) 300MG SA TAB UD |
| VA PRODUCT IDENTIFIER |
G0422 |
| TRANSMIT TO CMOP |
NO |
| VA DISPENSE UNIT |
TAB |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4035113 |
| EFFECTIVE DATE/TIME |
-
- 2015-11-23 00:00:00
- STATUS: ACTIVE
|
